SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-139464
Filing Date
2017-04-26
Accepted
2017-04-26 16:08:03
Documents
7
Effectiveness Date
2017-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A d43428ddefa14a.htm DEFA14A 48104
2 GRAPHIC g43428n1.jpg GRAPHIC 4329
3 GRAPHIC g43428n2.jpg GRAPHIC 3962
4 GRAPHIC g43428n3.jpg GRAPHIC 2493
5 GRAPHIC g43428n4.jpg GRAPHIC 2500
6 GRAPHIC g43428n5.jpg GRAPHIC 2500
7 GRAPHIC g43428n6.jpg GRAPHIC 2500
  Complete submission text file 0001193125-17-139464.txt   75264
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19311 | Film No.: 17784421
SIC: 2836 Biological Products, (No Diagnostic Substances)